Synthesis, Extraction and Biological Evaluations of Natural Products
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Natural Products Chemistry".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 19422
Special Issue Editor
Special Issue Information
Dear Colleagues,
Over recent decades, developed countries have had to deal with chronic degenerative diseases and pandemics closely related to the environment, modern lifestyles, and increasing life expectancy. Chronic inflammatory diseases are actually a significant burden on many patients, which may also increase the risk of certain cancers, as persistent inflammation results in DNA damage, which in turn could finally lead to various types of cancer. Considering the decrease in new drugs introduced to the market, along with nature’s high potential for yielding therapeutically relevant bioactive compounds, plant metabolites are emerging as new lead structures for the development of novel drugs for the prevention and cure of diseases. It is already the case that over 75% of anticancer compounds are either natural products or natural product-derived substances, whereas many anti-infective, anti-inflammatory, antioxidant, epigenetic and immunomodulatory agents come from nature. Biotargeted extraction guided by spectroscopy and metabolomic strategies, along with preliminary biological testing, supported by cancer cell lines, etc., followed by synthesis supported by docking analysis to enzymes/receptors would significantly accelerate the exploitation of natural products as sources of novel structures. The above modern approach has become a growing trend, which is expected to continue in the future.
Prof. Dr. George Albert Karikas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- degenerative
- cancer
- inflammation
- antioxidants
- bioactive compounds
- targeted extraction
- spectroscopy strategy
- cell lines
- docking
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.